ProQR Therapeutics (PRQR) Stock Chart & Stock Price History $2.16 0.00 (0.00%) Closing price 09/23/2025 04:00 PM EasternExtended Trading$2.18 +0.02 (+0.93%) As of 09/23/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProQR Therapeutics Stock Price Performance The ProQR Therapeutics (PRQR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 28.57%, with a year-to-date return of -18.49%. In the past month, the stock has decreased 4.42%, reflecting recent market activity. As of the latest close, ProQR Therapeutics traded at $2.16 with a market cap of $227.25 million and volume of 314,947 shares. Five years ago, the stock traded at $5.00, representing a 56.80% decrease over that period. At the time, it had a market cap of $250.72 million and a volume of 111,484 shares. Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.86%1 Month Performance-4.42%3 Month Performance+6.40%Year-To-Date Performance-18.49%1 Year Performance+28.57%5 Year Performance-56.80% PRQR Stock Chart for Wednesday, September, 24, 2025 PRQR Chart by TradingView ProQR Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/23/2025$2.16$2.16$2.19$2.11314,947 shs$227.25 million09/22/2025$2.10$2.16+2.86%$2.17$2.01227,300 shs$227.26 million09/19/2025$2.19$2.10-4.11%$2.19$2.10134,353 shs$220.95 million09/18/2025$2.06$2.19+6.31%$2.19$2.03379,866 shs$230.41 million09/17/2025$1.99$2.06+3.52%$2.10$1.99327,114 shs$216.73 million09/16/2025$1.99$1.99$2.00$1.91278,374 shs$209.37 million09/15/2025$2.19$1.99-9.13%$2.19$1.96437,957 shs$209.37 million09/12/2025$2.19$2.19$2.21$2.04472,345 shs$230.41 million09/11/2025$2.25$2.19-2.67%$2.25$2.10403,693 shs$230.41 million09/10/2025$2.33$2.25-3.43%$2.32$2.17260,688 shs$236.73 million Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/09/2025$2.33$2.33$2.34$2.26376,810 shs$245.14 million09/08/2025$2.45$2.33-4.90%$2.48$2.21432,135 shs$245.14 million09/05/2025$2.39$2.45+2.51%$2.50$2.36374,298 shs$257.77 million09/04/2025$2.43$2.39-1.65%$2.49$2.28299,992 shs$251.46 million09/03/2025$2.29$2.43+6.11%$2.49$2.22560,756 shs$255.66 million09/02/2025$2.25$2.29+1.78%$2.33$2.22446,805 shs$240.93 million09/01/2025$2.25$2.25$2.25$2.13152,458 shs$236.73 million08/29/2025$2.19$2.25+2.74%$2.25$2.13152,458 shs$236.73 million08/28/2025$2.21$2.19-0.90%$2.27$2.19425,892 shs$230.41 million08/27/2025$2.20$2.21+0.45%$2.27$2.18276,743 shs$232.51 million08/26/2025$2.25$2.20-2.22%$2.29$2.19396,635 shs$231.47 million08/25/2025$2.26$2.25-0.44%$2.29$2.22349,594 shs$236.72 million Related Companies uniQure Stock Chart Urogen Pharma Stock Chart Rapport Therapeutics Stock Chart Arbutus Biopharma Stock Chart Phathom Pharmaceuticals Stock Chart Taysha Gene Therapies Stock Chart Iovance Biotherapeutics Stock Chart Anavex Life Sciences Stock Chart Immunome Stock Chart ArriVent BioPharma Stock Chart Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRQR) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProQR Therapeutics N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProQR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.